Idera Pharmaceuticals, Inc.
(NASDAQ : IDRA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.09%84.520.9%$1038.45m
KITEKite Pharma, Inc.
0.18%179.6316.1%$788.56m
CELGCelgene Corporation
-0.52%144.191.1%$523.43m
AMGNAmgen Inc.
-0.13%186.051.1%$498.72m
BIIBBiogen Inc.
-0.26%316.701.2%$434.91m
REGNRegeneron Pharmaceuticals, Inc.
-0.40%436.382.7%$368.80m
ALNYAlnylam Pharmaceuticals, Inc
-4.23%112.1010.7%$258.89m
ALXNAlexion Pharmaceuticals, Inc.
-2.51%140.351.9%$232.47m
JUNOJuno Therapeutics, Inc.
-1.49%41.7014.6%$228.09m
INCYIncyte Corporation
-0.60%109.032.6%$223.70m
VRTXVertex Pharmaceuticals Incorporated
0.16%149.341.9%$216.67m
ILMNIllumina, Inc.
-1.22%198.933.5%$163.04m
BLUEBluebird Bio, Inc.
-2.45%127.3019.3%$145.71m
BMRNBioMarin Pharmaceutical Inc.
-1.29%93.174.4%$140.63m
CLVSClovis Oncology, Inc.
-2.86%73.7918.0%$133.64m

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The company uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.